HEADLINES International News

Sputnik V production begins in India, 100 million doses to be produced annually

The production of Russia’s COVID-19 vaccine Sputnik V has begun in India, the Russian Direct Investment Fund (RDIF) said on Monday (May 24).

The vaccine is being manufactured by Indian biotech firm Panacea Biotec Limited.

The first batch of the vaccine will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls.



Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea